Gossamer Bio Holds Special Stockholder Meeting
Bitget2026/10/28 20:03- Gossamer Bio shareholders approved potential common stock issuance at the October 27, 2026, special meeting.
- The authorization covers issuance exceeding 20% of common shares outstanding immediately before the initial closing under the August 20, 2026, Purchase Agreement.
- Covered shares include those issuable through Pre-Funded Warrants, FDA Approval Warrants and conversion of Series A-1, A-2 and A-3 Preferred Stock.
- The adjournment proposal was not put to a vote because shareholders approved the share issuance proposal.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
